<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03097692</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00009909</org_study_id>
    <nct_id>NCT03097692</nct_id>
  </id_info>
  <brief_title>Does Preconditioning Affects Other Organs in Patients Undergoing Open Heart Surgery ?</brief_title>
  <official_title>Variable Types of Preconditioning,is There a Different Impact Upon Multiorgan Function After Open Heart Surgery ?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An association between white blood cell count (WBC), neutrophil-lymphocyte ratio , and
      inflammatory process is well known . Ischemic preconditioning reduces the inflammation
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Preliminary evidence has suggested the role of inflammation in development and prognosis of
      cardiovascular diseases and cancers. Most of the prognostic studies failed to account for the
      effects of co-morbid conditions as these might have raised the systemic inflammation. We used
      neutrophil lymphocyte ratio (NLR) as a measure of systemic inflammation and investigated its
      association with cardiac preconditioning in open heart surgery .
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2016</start_date>
  <completion_date type="Actual">March 2017</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>intervention group well be pretreated with cardiac preconditioning</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change of Neutrophil lymphocyte ratio</measure>
    <time_frame>during first two postoperative days</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Neutrophil Lymphocyte Ratio</condition>
  <condition>Serum Createnine</condition>
  <condition>Mechanical Ventilation</condition>
  <arm_group>
    <arm_group_label>Ischemic preconditioing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>50 patients ischemic preconditioning will be done after induction and before cardiopulmonary bypass by inflation the cuff of blood pressure above 200mmhg in the lower limb every 5 min for 3cycles</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pharmacologic preconditioing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>by sevoflurane anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ischemic preconditioning</intervention_name>
    <description>ischemic preconditioning will be done after induction and before cardiopulmonary bypass by inflation the cuff of blood pressure above 200mmhg in the lower limb every 5 min for 3cycles</description>
    <arm_group_label>Ischemic preconditioing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pharmacologic preconditionig</intervention_name>
    <description>Pharmacologic preconditionig will be attained by sevoflurane anesthesia</description>
    <arm_group_label>Pharmacologic preconditioing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-60 years old

          -  American Society of Anesthesiologists physical status II and III

          -  Patients scheduled for open heart surgery

          -  no active inflammatory process

        Exclusion Criteria:Exclusion Criteria:

          -  Emergency surgery

          -  Clinically significant kidney or liver disease

          -  Patients allergic to local anesthetic

          -  Patients with prolonged cardiopulmonary bypass time (&gt;120 min)

          -  Patients required intra-aortic balloon pump

          -  Postoperative hemodynamic instability (including the occurrence of serious arrhythmia)
             or bleeding that required surgical re-exploration
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Emad Zarief Kamel Said</name>
      <address>
        <city>Assiut</city>
        <zip>71111</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 21, 2017</study_first_submitted>
  <study_first_submitted_qc>March 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 31, 2017</study_first_posted>
  <last_update_submitted>December 20, 2017</last_update_submitted>
  <last_update_submitted_qc>December 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Emad Zarief , MD</investigator_full_name>
    <investigator_title>Lecturer of Anesthesia and critical care Medicine</investigator_title>
  </responsible_party>
  <keyword>cardiac preconditioning</keyword>
  <keyword>open heart surgery</keyword>
  <keyword>createnine</keyword>
  <keyword>inflammation</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

